These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. [Effects of four beta-blocking agents on some psychopharmacological tests in mice (author's transl)]. Francès H; Puech AJ; Chermat R; Simon P Psychopharmacology (Berl); 1979 May; 63(1):43-8. PubMed ID: 38471 [TBL] [Abstract][Full Text] [Related]
46. The effects of -blocking drugs on atrioventricular conduction and contractility. Fitzgerald JD; Wale J Cardiology; 1971; 56(1):338-43. PubMed ID: 4403201 [No Abstract] [Full Text] [Related]
47. Influence of vesicular storage and monoamine oxidase activity on [11C]phenylephrine kinetics: studies in isolated rat heart. Raffel DM; Wieland DM J Nucl Med; 1999 Feb; 40(2):323-30. PubMed ID: 10025842 [TBL] [Abstract][Full Text] [Related]
48. Uptake and metabolism of catecholamines in rat brain synaptosomes: studies on the contribution of monoamine oxidase. Urwyler S; von Wartburg JP Biochem Pharmacol; 1981 Oct; 30(20):2777-85. PubMed ID: 7332636 [No Abstract] [Full Text] [Related]
49. Modification by propranolol and related compounds of motor activity and stereotype behaviour induced in the rat by amphetamine. Weinstock M; Speiser Z Eur J Pharmacol; 1974 Jan; 25(1):29-35. PubMed ID: 4279823 [No Abstract] [Full Text] [Related]
51. Cardiac actions of oxprenolol as studied in dog heart-lung preparations. Takeda K; Iizuka H; Imai S Arzneimittelforschung; 1973 Oct; 23(10):1446-50. PubMed ID: 4149692 [No Abstract] [Full Text] [Related]
52. N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl. Karoum F Br J Pharmacol; 1987 Feb; 90(2):335-45. PubMed ID: 3103805 [TBL] [Abstract][Full Text] [Related]
53. Comparison of the effects on renin release of beta adrenergic antagonists with differing properties. Weber MA; Stokes GS; Gain JM J Clin Invest; 1974 Dec; 54(6):1413-9. PubMed ID: 4154950 [TBL] [Abstract][Full Text] [Related]
54. Effects of beta adrenergic blockade on plasma catecholamines in exercise. Irving MH; Britton BJ; Wood WG; Padgham C; Carruthers M Nature; 1974 Apr; 248(448):531-3. PubMed ID: 4150965 [No Abstract] [Full Text] [Related]
55. Pharmacology of the mechanism of certain effects of reserpine in the rat. Fischer E; Heller B Nature; 1967 Dec; 216(5121):1221-2. PubMed ID: 4383823 [No Abstract] [Full Text] [Related]
56. The effects of high doses of oxprenolol and of propranolol on pursuit rotor performance, reaction time and critical flicker frequency. Ogle CW; Turner P; Markomihelakis H Psychopharmacologia; 1976 Apr; 46(3):295-9. PubMed ID: 951465 [TBL] [Abstract][Full Text] [Related]
57. Beta-blockade and ischaemic injury: effects of partial agonist activity. Manning AS; Keogh JM; Hearse DJ; Coltart DJ Cardiovasc Res; 1980 Dec; 14(11):619-23. PubMed ID: 7226171 [TBL] [Abstract][Full Text] [Related]
58. The antihypertensive action of several beta-adrenoreceptor-blocking drugs. Waal-Manning HJ N Z Med J; 1976 Apr; 83(561):223-6. PubMed ID: 8748 [TBL] [Abstract][Full Text] [Related]
59. Selectivity of clorgyline and pargyline as inhibitors of monoamine oxidases A and B in vivo in man. Murphy DL; Lipper S; Slater S; Shiling D Psychopharmacology (Berl); 1979 Apr; 62(2):129-32. PubMed ID: 111275 [TBL] [Abstract][Full Text] [Related]
60. [Basis for the use of beta-receptor blockaders in the practice]. Blankart R Schweiz Rundsch Med Prax; 1973 Aug; 62(32):975-8. PubMed ID: 4147247 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]